Metabolism of thrombopoietin (TPO) in vivo : Determination of the binding dynamics for TPO in mice
Previous in vivo studies have established that plasma thrombopoietin (TPO) levels are regulated by binding to c-Mpl on platelets and that, in vitro, platelets bind and degrade TPO. To determine if the in vivo metabolism of TPO was specific and saturable, we injected normal CD-1 mice IV with trace am...
Saved in:
Published in | Blood Vol. 89; no. 11; pp. 4063 - 4070 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Washington, DC
The Americain Society of Hematology
01.06.1997
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Previous in vivo studies have established that plasma thrombopoietin (TPO) levels are regulated by binding to c-Mpl on platelets and that, in vitro, platelets bind and degrade TPO. To determine if the in vivo metabolism of TPO was specific and saturable, we injected normal CD-1 mice IV with trace amounts of 125I-rmTPO with or without a saturating concentration of rmTPO. The amount of radioactivity present in the spleen, blood cell fraction, platelet fraction, tibia/fibula, and femur was significantly greater in the mice receiving 125I-rmTPO alone. Conversely, the amount of radioactivity present in the plasma was significantly greater in the mice receiving both 125I-rmTPO and rmTPO, thus suggesting the uptake of rmTPO by the spleen, platelets, and bone marrow in vivo was saturable. Platelet and spleen homogenates from animals receiving 125I-rmTPO alone showed a degradation pattern of 125I-rmTPO similar to that observed in vitro using mouse platelet rich plasma. To determine the in vivo binding dynamics for rmTPO, mice were injected with 125I-rmTPO alone or with increasing concentrations of rmTPO; spleen and blood cell-associated radioactivity was determined at 2 hours postinjection. A 4-parameter curve fit of the data indicated that the "in vivo binding affinity" for rmTPO was approximately 6.4 microg/kg. These data indicate that after a dose of approximately 6.4 microg/kg, 50% of all c-Mpl receptors will be saturated with rmTPO. Electron microscopy indicated that radioactivity was present bound to and within megakaryocytes and platelets in both sternum and spleen and platelets in circulation. Together these data demonstrate that in vivo, 125I-rmTPO is mainly metabolized by platelets and to a small extent by cells of the megakaryocyte lineage, via a specific and saturable mechanism. |
---|---|
AbstractList | Previous in vivo studies have established that plasma thrombopoietin (TPO) levels are regulated by binding to c-Mpl on platelets and that, in vitro, platelets bind and degrade TPO. To determine if the in vivo metabolism of TPO was specific and saturable, we injected normal CD-1 mice IV with trace amounts of 125I-rmTPO with or without a saturating concentration of rmTPO. The amount of radioactivity present in the spleen, blood cell fraction, platelet fraction, tibia/fibula, and femur was significantly greater in the mice receiving 125I-rmTPO alone. Conversely, the amount of radioactivity present in the plasma was significantly greater in the mice receiving both 125I-rmTPO and rmTPO, thus suggesting the uptake of rmTPO by the spleen, platelets, and bone marrow in vivo was saturable. Platelet and spleen homogenates from animals receiving 125I-rmTPO alone showed a degradation pattern of 125I-rmTPO similar to that observed in vitro using mouse platelet rich plasma. To determine the in vivo binding dynamics for rmTPO, mice were injected with 125I-rmTPO alone or with increasing concentrations of rmTPO; spleen and blood cell-associated radioactivity was determined at 2 hours postinjection. A 4-parameter curve fit of the data indicated that the "in vivo binding affinity" for rmTPO was approximately 6.4 microg/kg. These data indicate that after a dose of approximately 6.4 microg/kg, 50% of all c-Mpl receptors will be saturated with rmTPO. Electron microscopy indicated that radioactivity was present bound to and within megakaryocytes and platelets in both sternum and spleen and platelets in circulation. Together these data demonstrate that in vivo, 125I-rmTPO is mainly metabolized by platelets and to a small extent by cells of the megakaryocyte lineage, via a specific and saturable mechanism. Abstract Previous in vivo studies have established that plasma thrombopoietin (TPO) levels are regulated by binding to c-Mpl on platelets and that, in vitro, platelets bind and degrade TPO. To determine if the in vivo metabolism of TPO was specific and saturable, we injected normal CD-1 mice IV with trace amounts of 125I-rmTPO with or without a saturating concentration of rmTPO. The amount of radioactivity present in the spleen, blood cell fraction, platelet fraction, tibia/fibula, and femur was significantly greater in the mice receiving 125I-rmTPO alone. Conversely, the amount of radioactivity present in the plasma was significantly greater in the mice receiving both 125I-rmTPO and rmTPO, thus suggesting the uptake of rmTPO by the spleen, platelets, and bone marrow in vivo was saturable. Platelet and spleen homogenates from animals receiving 125I-rmTPO alone showed a degradation pattern of 125I-rmTPO similar to that observed in vitro using mouse platelet rich plasma. To determine the in vivo binding dynamics for rmTPO, mice were injected with 125I-rmTPO alone or with increasing concentrations of rmTPO; spleen and blood cell-associated radioactivity was determined at 2 hours postinjection. A 4-parameter curve fit of the data indicated that the “in vivo binding affinity” for rmTPO was approximately 6.4 μg/kg. These data indicate that after a dose of approximately 6.4 μg/kg, 50% of all c-Mpl receptors will be saturated with rmTPO. Electron microscopy indicated that radioactivity was present bound to and within megakaryocytes and platelets in both sternum and spleen and platelets in circulation. Together these data demonstrate that in vivo, 125I-rmTPO is mainly metabolized by platelets and to a small extent by cells of the megakaryocyte lineage, via a specific and saturable mechanism. |
Author | WIDMER, R STEFANICH, E FIELDER, P. J SENN, T FRATINO, C KELLER, G.-K |
Author_xml | – sequence: 1 givenname: E surname: STEFANICH fullname: STEFANICH, E organization: Department of Pharmacokinetics and Metabolism, Genentech Inc, S San Francisco, CA 94080, United States – sequence: 2 givenname: T surname: SENN fullname: SENN, T organization: Department of Pharmacokinetics and Metabolism, Genentech Inc, S San Francisco, CA 94080, United States – sequence: 3 givenname: R surname: WIDMER fullname: WIDMER, R organization: Department of Pharmacokinetics and Metabolism, Genentech Inc, S San Francisco, CA 94080, United States – sequence: 4 givenname: C surname: FRATINO fullname: FRATINO, C organization: Department of Pharmacokinetics and Metabolism, Genentech Inc, S San Francisco, CA 94080, United States – sequence: 5 givenname: G.-K surname: KELLER fullname: KELLER, G.-K organization: Department of Pharmacokinetics and Metabolism, Genentech Inc, S San Francisco, CA 94080, United States – sequence: 6 givenname: P. J surname: FIELDER fullname: FIELDER, P. J organization: Department of Pharmacokinetics and Metabolism, Genentech Inc, S San Francisco, CA 94080, United States |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2678842$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/9166846$$D View this record in MEDLINE/PubMed |
BookMark | eNo9kLtOAzEQRS0ECkngAyiQXFBAscGv9dp0KDyloFAE2pXt9YJR1o7sJVL-HodEqWau5p4pzggc--AtABcYTTAW5FYvQ2gmayFznDDE6REY4pKIAiGCjsEQIcQLJit8CkYp_SCEGSXlAAwk5lwwPgT6zfZKh6VLHQwt7L9j6HRYBWd75-H14n1-A_OydusA7-CD7W3snFe9C37Xt1A73zj_BZuNV50zCbYhwgxuuZztGThp1TLZ8_0cg4-nx8X0pZjNn1-n97PCUC76QmFkmEFGIW4sU7TkTHJVSdFSJZTkkgvLrKiIYIKXKJcbS7hBulFaUmbpGODdXxNDStG29Sq6TsVNjVG91VX_66o_hcyx3urKzOWOWf3qzjYHYu8n36_2d5WMWrZReePSoUZ4JQQj9A-_NHV5 |
CitedBy_id | crossref_primary_10_1016_j_hoc_2013_03_004 crossref_primary_10_1038_labinvest_3700514 crossref_primary_10_1203_00006450_200002000_00010 crossref_primary_10_1016_S0025_7753_00_71347_9 crossref_primary_10_1517_13543780902905848 crossref_primary_10_1016_j_jtbi_2009_12_032 crossref_primary_10_1111_j_1742_4658_2006_05567_x crossref_primary_10_1002_jca_21254 crossref_primary_10_1002_stem_160375 crossref_primary_10_3109_08977199909001059 crossref_primary_10_1002_stem_5530160719 crossref_primary_10_1177_107602960200800301 crossref_primary_10_1182_blood_2002_11_3468 crossref_primary_10_1182_blood_V92_3_822_415a16_822_833 crossref_primary_10_1182_blood_V92_3_822 crossref_primary_10_1182_blood_V98_9_2720 crossref_primary_10_1182_blood_2017_12_820779 crossref_primary_10_1046_j_1365_2257_1999_00226_x crossref_primary_10_1111_liv_12908 crossref_primary_10_1046_j_1365_2141_1999_01571_x crossref_primary_10_1016_S0022_5193_03_00090_0 crossref_primary_10_1111_j_1365_2036_2007_03511_x crossref_primary_10_4065_78_2_174 crossref_primary_10_3109_10428199909167396 crossref_primary_10_1016_S0022_2143_98_90054_3 crossref_primary_10_1182_blood_V92_5_1586_417a07_1586_1597 crossref_primary_10_1002_stem_5530160716 crossref_primary_10_1111_jcmm_15785 crossref_primary_10_1182_blood_2004_10_4019 crossref_primary_10_1182_blood_V92_5_1586 crossref_primary_10_1177_00912700222011553 crossref_primary_10_1016_S0145_2126_02_00088_7 crossref_primary_10_1182_blood_V93_8_2515 crossref_primary_10_1046_j_1365_2141_2003_04259_x crossref_primary_10_1182_blood_V93_8_2515_408k10_2515_2524 crossref_primary_10_1016_S0950_3536_98_80058_9 crossref_primary_10_1111_j_1600_0609_2004_00288_x |
Cites_doi | 10.1073/pnas.91.23.11104 10.1182/blood.V76.1.50.50 10.1016/0090-6980(82)90135-6 10.1023/A:1018943613122 10.1084/jem.183.2.651 10.1182/blood.V85.4.981.bloodjournal854981 10.1677/joe.0.1390383 10.1182/blood.V85.10.2720.bloodjournal85102720 10.1182/blood.V75.1.74.74 10.1172/JCI115568 10.1038/369565a0 10.1111/j.1749-6632.1949.tb27297.x 10.1182/blood.V85.7.1719.bloodjournal8571719 10.1126/science.8073287 10.1111/j.1365-2141.1967.tb08753.x 10.1073/pnas.84.17.6179 10.1055/s-0038-1646890 10.1182/blood.V74.4.1303.1303 10.1038/369568a0 10.1016/0092-8674(94)90450-2 10.1038/369533a0 10.1182/blood.V48.5.765.bloodjournal485765 10.1172/JCI105935 10.1182/blood.V42.3.413.413 10.1038/369571a0 10.1182/blood.V87.6.2154.bloodjournal8762154 |
ContentType | Journal Article |
Copyright | 1997 INIST-CNRS |
Copyright_xml | – notice: 1997 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION |
DOI | 10.1182/blood.v89.11.4063 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Biology Anatomy & Physiology |
EISSN | 1528-0020 |
EndPage | 4070 |
ExternalDocumentID | 10_1182_blood_V89_11_4063 9166846 2678842 |
Genre | Journal Article |
GroupedDBID | --- -~X .55 .GJ 08R 1CY 23N 2WC 34G 39C 4.4 53G 5GY 5RE 5VS 6J9 9M8 AAQQT AAXUO ABFLS ABOCM ABPTK ABVKL ACGFO ADBBV ADGIM AENEX AFETI AFFNX AFOSN AI. ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW C1A CS3 DIK DU5 E3Z EBS EJD EX3 F5P FDB FRP GS5 GX1 H13 IH2 IQODW J5H K-O KQ8 L7B LSO MJL MVM N4W N9A OHT OK1 P2P R.V RHF RHI ROL SJN THE TR2 TWZ UCJ VH1 W2D W8F WH7 WHG WOQ WOW X7M YHG YKV ZA5 ZGI ZXP 0R~ 0SF AAEDW AALRI ADVLN AITUG AKRWK AMRAJ CGR CUY CVF ECM EIF NPM AAYXX CITATION |
ID | FETCH-LOGICAL-c368t-a10c4c0ca06ce4a356496a798f3a8a96968e4e8728486500c4de26c0bdab934e3 |
ISSN | 0006-4971 |
IngestDate | Fri Aug 23 01:16:57 EDT 2024 Sat Sep 28 08:44:12 EDT 2024 Fri Nov 25 06:04:46 EST 2022 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | Spleen Radiolabelling Cytokine Rodentia Megakaryocyte Electron microscopy Metabolism Blood Thrombopoietin Autoradiography In vivo Vertebrata Regulation(control) Platelet Mammalia Fixation Mouse Animal Bone marrow |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c368t-a10c4c0ca06ce4a356496a798f3a8a96968e4e8728486500c4de26c0bdab934e3 |
OpenAccessLink | https://ashpublications.org/blood/article-pdf/89/11/4063/1035668/4063.pdf |
PMID | 9166846 |
PageCount | 8 |
ParticipantIDs | crossref_primary_10_1182_blood_V89_11_4063 pubmed_primary_9166846 pascalfrancis_primary_2678842 |
PublicationCentury | 1900 |
PublicationDate | 1997-06-01 |
PublicationDateYYYYMMDD | 1997-06-01 |
PublicationDate_xml | – month: 06 year: 1997 text: 1997-06-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | Washington, DC |
PublicationPlace_xml | – name: Washington, DC – name: United States |
PublicationTitle | Blood |
PublicationTitleAlternate | Blood |
PublicationYear | 1997 |
Publisher | The Americain Society of Hematology |
Publisher_xml | – name: The Americain Society of Hematology |
References | de Sauvage (2019111908575496100_B1) 1994; 369 Gurney (2019111908575496100_B14) 1994; 265 Lok (2019111908575496100_B2) 1994; 369 Kaushansky (2019111908575496100_B4) 1994; 369 Fielder (2019111908575496100_B11) 1996; 87 Metcalf (2019111908575496100_B17) 1990; 76 Vargas (2019111908575496100_B20) 1982; 23 Broudy (2019111908575496100_B6) 1995; 85 Scatchard (2019111908575496100_B26) 1949; 51 de Sauvage (2019111908575496100_B13) 1996; 183 Layton (2019111908575496100_B30) 1989; 74 de Gabriele (2019111908575496100_B9) 1967; 13 Massart (2019111908575496100_B21) 1993; 139 Gurney (2019111908575496100_B18) 1995; 85 Kuter (2019111908575496100_B7) 1994; 91 2019111908575496100_B16 2019111908575496100_B15 2019111908575496100_B12 Jakeman (2019111908575496100_B19) 1992; 89 Jackson (2019111908575496100_B24) 1973; 42 Nachman (2019111908575496100_B28) 1968; 47 Kuter (2019111908575496100_B8) 1995; 85 Bartley (2019111908575496100_B3) 1994; 77 Li (2019111908575496100_B23) 1996; 12 Davies (2019111908575496100_B22) 1993; 10 Behnke (2019111908575496100_B27) 1989; 62 Vadhan-Raj (2019111908575496100_B29) 1996; 15 Wendling (2019111908575496100_B5) 1994; 369 Odell (2019111908575496100_B25) 1976; 48 Kuter (2019111908575496100_B10) 1990; 75 Bartocci (2019111908575496100_B31) 1987; 84 |
References_xml | – volume: 91 start-page: 11104 year: 1994 ident: 2019111908575496100_B7 article-title: The purification of megapoietin: A physiological regulator of megakaryocyte growth and platelet production. publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.91.23.11104 contributor: fullname: Kuter – volume: 76 start-page: 50 year: 1990 ident: 2019111908575496100_B17 article-title: Effects of injected leukemia inhibitory factor on hematopoietic and other tissues in mice. publication-title: Blood doi: 10.1182/blood.V76.1.50.50 contributor: fullname: Metcalf – volume: 23 start-page: 929 year: 1982 ident: 2019111908575496100_B20 article-title: The use of prostacyclin in the separation from plasma and washing of human platelets. publication-title: Prostaglandin doi: 10.1016/0090-6980(82)90135-6 contributor: fullname: Vargas – ident: 2019111908575496100_B12 – volume: 10 start-page: 1093 year: 1993 ident: 2019111908575496100_B22 article-title: Physiological parameters in laboratory animals and humans. publication-title: Pharm Res doi: 10.1023/A:1018943613122 contributor: fullname: Davies – volume: 183 start-page: 651 year: 1996 ident: 2019111908575496100_B13 article-title: Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. publication-title: J Exp Med doi: 10.1084/jem.183.2.651 contributor: fullname: de Sauvage – volume: 85 start-page: 981 year: 1995 ident: 2019111908575496100_B18 article-title: Genomic structure, chromosomal localization, and conserved alternative splice forms of thrombopoietin. publication-title: Blood doi: 10.1182/blood.V85.4.981.bloodjournal854981 contributor: fullname: Gurney – volume: 139 start-page: 383 year: 1993 ident: 2019111908575496100_B21 article-title: Monoclonal antibodies to bovine growth hormone potentiate hormonal activity in vivo by enhancing growth hormone binding to hepatic somatogenic receptors. publication-title: J Endocrinol doi: 10.1677/joe.0.1390383 contributor: fullname: Massart – ident: 2019111908575496100_B16 – volume: 15 start-page: 24 year: 1996 ident: 2019111908575496100_B29 article-title: Single-dose therapy with recombinant human thrombopoietin (rhTPO) in patients receiving cytotoxic chemotherapy. publication-title: Am Soc Clin Oncol contributor: fullname: Vadhan-Raj – volume: 12 start-page: 2473 year: 1996 ident: 2019111908575496100_B23 article-title: Heregulin is rapidly translocated to the nucleus and its transport is correlated with c-myc induction in breast cancer cells. publication-title: Oncogene contributor: fullname: Li – volume: 85 start-page: 2720 year: 1995 ident: 2019111908575496100_B8 article-title: The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. publication-title: Blood doi: 10.1182/blood.V85.10.2720.bloodjournal85102720 contributor: fullname: Kuter – volume: 75 start-page: 74 year: 1990 ident: 2019111908575496100_B10 article-title: Regulation of megakaryocyte ploidy in vivo in the rat. publication-title: Blood doi: 10.1182/blood.V75.1.74.74 contributor: fullname: Kuter – volume: 89 start-page: 244 year: 1992 ident: 2019111908575496100_B19 article-title: Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. publication-title: J Clin Invest doi: 10.1172/JCI115568 contributor: fullname: Jakeman – volume: 369 start-page: 565 year: 1994 ident: 2019111908575496100_B2 article-title: Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. publication-title: Nature doi: 10.1038/369565a0 contributor: fullname: Lok – volume: 51 start-page: 600 year: 1949 ident: 2019111908575496100_B26 article-title: The attractions of proteins for small molecules and ions. publication-title: Ann NY Acad Sci doi: 10.1111/j.1749-6632.1949.tb27297.x contributor: fullname: Scatchard – volume: 85 start-page: 1719 year: 1995 ident: 2019111908575496100_B6 article-title: Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. publication-title: Blood doi: 10.1182/blood.V85.7.1719.bloodjournal8571719 contributor: fullname: Broudy – volume: 265 start-page: 1445 year: 1994 ident: 2019111908575496100_B14 article-title: Thrombocytopenia in c-mpl-deficient mice. publication-title: Science doi: 10.1126/science.8073287 contributor: fullname: Gurney – volume: 13 start-page: 384 year: 1967 ident: 2019111908575496100_B9 article-title: Regulation of platelet production: “Hypersplenism” in the experimental animal. publication-title: Br J Haematol doi: 10.1111/j.1365-2141.1967.tb08753.x contributor: fullname: de Gabriele – ident: 2019111908575496100_B15 – volume: 84 start-page: 6179 year: 1987 ident: 2019111908575496100_B31 article-title: Macrophages specifically regulate the concentration of their own growth factor in the circulation. publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.84.17.6179 contributor: fullname: Bartocci – volume: 62 start-page: 718 year: 1989 ident: 2019111908575496100_B27 article-title: Coated pits and vesicles transfer plasma components to platelet granules. publication-title: Thromb Haemost doi: 10.1055/s-0038-1646890 contributor: fullname: Behnke – volume: 74 start-page: 1303 year: 1989 ident: 2019111908575496100_B30 article-title: Evidence for a novel in vivo control mechanism of granulopoiesis: Mature cell-related control of a regulatory growth factor. publication-title: Blood doi: 10.1182/blood.V74.4.1303.1303 contributor: fullname: Layton – volume: 369 start-page: 568 year: 1994 ident: 2019111908575496100_B4 article-title: Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. publication-title: Nature doi: 10.1038/369568a0 contributor: fullname: Kaushansky – volume: 77 start-page: 1117 year: 1994 ident: 2019111908575496100_B3 article-title: Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. publication-title: Cell doi: 10.1016/0092-8674(94)90450-2 contributor: fullname: Bartley – volume: 369 start-page: 533 year: 1994 ident: 2019111908575496100_B1 article-title: Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. publication-title: Nature doi: 10.1038/369533a0 contributor: fullname: de Sauvage – volume: 48 start-page: 765 year: 1976 ident: 2019111908575496100_B25 article-title: Stimulation of megakaryocytopoiesis by acute thrombocytopenia in rats. publication-title: Blood doi: 10.1182/blood.V48.5.765.bloodjournal485765 contributor: fullname: Odell – volume: 47 start-page: 2530 year: 1968 ident: 2019111908575496100_B28 article-title: Studies on human platelet protease activity. publication-title: J Clin Invest doi: 10.1172/JCI105935 contributor: fullname: Nachman – volume: 42 start-page: 413 year: 1973 ident: 2019111908575496100_B24 article-title: Cholinesterase as a possible marker for early cells of the megakaryocytic series. publication-title: Blood doi: 10.1182/blood.V42.3.413.413 contributor: fullname: Jackson – volume: 369 start-page: 571 year: 1994 ident: 2019111908575496100_B5 article-title: cMpl ligand is a humoral regulator of megakaryocytopoiesis. publication-title: Nature doi: 10.1038/369571a0 contributor: fullname: Wendling – volume: 87 start-page: 2154 year: 1996 ident: 2019111908575496100_B11 article-title: Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. publication-title: Blood doi: 10.1182/blood.V87.6.2154.bloodjournal8762154 contributor: fullname: Fielder |
SSID | ssj0014325 |
Score | 1.7626492 |
Snippet | Previous in vivo studies have established that plasma thrombopoietin (TPO) levels are regulated by binding to c-Mpl on platelets and that, in vitro, platelets... Abstract Previous in vivo studies have established that plasma thrombopoietin (TPO) levels are regulated by binding to c-Mpl on platelets and that, in vitro,... |
SourceID | crossref pubmed pascalfrancis |
SourceType | Aggregation Database Index Database |
StartPage | 4063 |
SubjectTerms | Analytical, structural and metabolic biochemistry Animals Binding Sites Biological and medical sciences Female Fundamental and applied biological sciences. Psychology Mice Microscopy, Electron Protein hormones. Growth factors. Cytokines Proteins Recombinant Proteins - metabolism Recombinant Proteins - pharmacokinetics Thrombopoietin - metabolism Thrombopoietin - pharmacokinetics Tissue Distribution |
Title | Metabolism of thrombopoietin (TPO) in vivo : Determination of the binding dynamics for TPO in mice |
URI | https://www.ncbi.nlm.nih.gov/pubmed/9166846 |
Volume | 89 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKEBcJIeg2UWDIDwgBU4prO4nD2xigDVRuyqa9RY7jiEpbUo0MCf4Cf5rjSy4dQ2K8RKkTO23Pl5Nz4s_nQ-gx0UVZxDELVCKKgEOGEkiqNGQpSSRyRSLt2BYfor0D_u4oPBqNfg1YS2dNPlU_L1xX8j9WhTawq1klewnLdoNCA-yDfWELFobtP9l4rhuw4bHRuYCYL_16Wp_k9bJemGXMJnRMP300Wf9-tX24-G6uBu7Fs1_aQNHyAxZuactrp05vKzRsQ1_zLmTuuXHdxO-xV5f3ZOBSVgunJmU8andAu7A4NUWL-lc7hZdq-WIkjjrkGAxWdV_poJ3pL_zivLjnTHX-NTKada5Je5dqamATSoY-18kGtdiaDTwoBBhs8DSGfJNc7OmFqRxr2f3TQ5FAw7TvOqyqfe5p13EQbfYjaGaHyGAI-JiZIa6gqzROQsMPff-5n5LijDo5DP8T_RQ5DPHij2-xEuTcWspvcL-VTijlXPpiw5j0Drrt8w-848B0F410NUbrOwCI-uQHfoItI9hOtYzRtVft3o3dVhdwjK7PPR1jHckegLgu8SoA8VOA0DO8X2EDvpd4BXrmdIAe9tDDLfQwQA9DPwz9DfQ20MHbN-nuXuA1OwLFItEEckYUV0RJEinNJQsjnkQyTkTJpJC2FJPmWsQQFQlIDuDkQtNIkbyQecK4ZptoraorfQ9hnuu8oCxUYWHKAhLBE6q4IFrORKzYbIKet39ytnSlWbK_GnWCtlbM0PWgEK0JTido05mlOwB5UwTB-f3LXOUButnfFg_RWnN6prcgaG3yRxZMvwHY95Ly |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Metabolism+of+Thrombopoietin+%28TPO%29+In+Vivo%3A+Determination+of+the+Binding+Dynamics+for+TPO+in+Mice&rft.jtitle=Blood&rft.au=Stefanich%2C+Eric&rft.au=Senn%2C+Tauri&rft.au=Widmer%2C+Ramon&rft.au=Fratino%2C+Christine&rft.date=1997-06-01&rft.issn=0006-4971&rft.eissn=1528-0020&rft.volume=89&rft.issue=11&rft.spage=4063&rft.epage=4070&rft_id=info:doi/10.1182%2Fblood.V89.11.4063&rft.externalDBID=n%2Fa&rft.externalDocID=10_1182_blood_V89_11_4063 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-4971&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-4971&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-4971&client=summon |